This cluster is routine and does not signal a material change in insider conviction. The selling is trivial relative to market cap, clustered around options expiry and tax withholding, which is a common pattern. The small director purchase adds no counterweight. No trading action warranted based on insider activity alone.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 2 $19.12entry
- T+1 · 4mo ago −0.21%α −1.08% · $19.08
- T+5 · 4mo ago +7.17%α +5.80% · $20.49
- T+20 · 4mo ago −4.45%α −4.75% · $18.27
- T+60 · 7w ago +34.36%α +31.57% · $25.69
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at Zai Lab (CEO, CLO, CFO) sold a net ~$242K in open-market shares over a 5-day window ending June 30, 2026. CEO Du Ying also engaged in stock-settled derivative exercises and tax-withholding surrenders (non-cash). At a $2.1B market cap, the open-market sales are ~0.01% of market cap, trivial in proportion, consistent with routine portfolio management and tax planning following option exercises. No material directional signal.
Key Financial Metrics
Key Facts
- Chairperson & CEO Du Ying exercised 40,096 shares of derivatives at $0 exercise price (non-cash), then surrendered 11,431 shares for tax withholding (~$219K).
- CEO Du Ying also sold 7,000 open-market shares on June 30 for $130K.
- Chief Legal Officer sold 4,100 shares on June 26 for $72K.
- Chief Financial Officer sold 2,300 shares on June 26 for $40K.
- Total open-market sales by all insiders combined: ~$242K, or ~0.012% of ZLAB's $2.1B market cap.
- Director GAYNOR RICHARD made a small open-market purchase of $33K on July 1, partially offsetting the selling pattern.
Financial Impact
Insider open-market sales of ~$242K represent 0.012% of Zai Lab's $2.1B market cap, immaterial. The CEO's derivative exercises and tax-withholding transactions involved no net cash to the executive.
Risk Factors
- Insider selling is a modest negative signal in theory, but at this scale it is indistinguishable from noise.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ZLAB-1783409177412 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Viewing Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers